APLM
Apollomics·NASDAQ
--
--(--)
--
--(--)
APLM fundamentals
During H1 2025, Apollomics (APLM) reported revenue of 8.50M, a YoY change of 0.00%. Net income was -12.54M, a YoY change of 64.39%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
FY,2020 | H1,2021 | 9M,2021 | FY,2021 | Q1,2022 | H1,2022 | 9M,2022 | FY,2022 | H1,2023 | FY,2023 | H1,2024 | FY,2024 | H1,2025 | TTM |
|---|
Start Date | Jan 1, 2020 | Jun 2, 2021 | Jun 2, 2021 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2023 | Jan 1, 2023 | Jan 1, 2024 | Jan 1, 2024 | Jan 1, 2025 | -- |
End Date | Dec 31, 2020 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Jun 30, 2023 | Dec 31, 2023 | Jun 30, 2024 | Dec 31, 2024 | Jun 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 8.50M -- | -- -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 8.50M -- | -- -- |
Other Operating Income | 2.06M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 43.48M -- | 1.45K -- | 5.83K -- | 53.86M +23.86% | 389.37K -- | 27.10M +1875609.34% | 1.39M +23685.11% | 45.40M -15.70% | 73.63M +171.65% | 54.83M +20.77% | 37.17M -49.52% | 55.33M +0.91% | 20.62M -44.52% | 38.79M -- |
Selling, General and Administrative Expenses | 11.04M -- | 1.45K -- | 5.83K -- | 15.29M +38.47% | 389.37K -- | 5.10M +352633.56% | 1.39M +23685.11% | 9.95M -34.95% | 9.65M +89.37% | 20.64M +107.51% | 10.15M +5.19% | 17.77M -13.92% | 14.49M +42.70% | 22.10M -- |
General and Administrative Expenses | 11.04M -- | -- -- | -- -- | 15.29M +38.47% | -- -- | 5.10M -- | -- -- | 9.95M -34.95% | 9.65M +89.37% | 20.64M +107.51% | 10.15M +5.19% | 17.77M -13.92% | 14.49M +42.70% | 22.10M -- |
Research and Development Expenses | 31.44M -- | -- -- | -- -- | 35.57M +13.13% | -- -- | 18.00M -- | -- -- | 35.46M -0.31% | 16.52M -8.23% | 34.19M -3.56% | 16.93M +2.47% | 24.57M -28.15% | 4.62M -72.70% | 12.26M -- |
Loss on Impairment of Other Assets | 1.00M -- | -- -- | -- -- | 3.00M +200.00% | -- -- | -- -- | -- -- | 0 -100.00% | 0 -- | 0 -- | 10.00M -- | 13.00M -- | 1.50M -85.00% | 4.50M -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | 4.01M -- | -- -- | -- -- | 47.46M +1084.06% | -- -- | 90.00K -99.81% | -- -- | 14.00K -84.44% | -- -- |
Operating Income | -41.42M -- | -1.45K -- | -5.83K -- | -53.86M -30.02% | -389.37K -- | -27.10M -1875609.34% | -1.39M -23685.11% | -45.40M +15.70% | -73.63M -171.65% | -54.83M -20.77% | -37.17M +49.52% | -55.33M -0.91% | -12.12M +67.39% | -30.29M -- |
Non-Operating Income (Loss) | -33.48M -- | -- -- | -- -- | -40.94M -22.27% | 33.40K -- | 23.69M -- | 734.59K -- | -195.41M -377.33% | -77.06M -425.30% | -117.76M +39.74% | 1.96M +102.55% | 1.74M +101.47% | -413.00K -121.04% | -641.00K -- |
Gain (Loss) on Change in Fair Value | -26.46M -- | -- -- | -- -- | -37.42M -41.41% | -- -- | 23.70M -- | -- -- | -189.32M -405.91% | -75.29M -417.68% | -74.01M +60.91% | 362.00K +100.48% | 420.00K +100.57% | -384.00K -206.08% | -326.00K -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -- -- | -- -- | -- -- | -- -- | -725.00K -- | -- -- | -829.00K -- | -2.10M -190.21% | 1.19M +243.67% | -2.00K +99.90% | 145.00K -87.83% | -77.00K -3750.00% | 70.00K -- |
Other Non-Operating Income (Loss) | -6.95M -- | -- -- | -- -- | -3.90M +43.86% | 33.40K -- | 563.00K -- | 734.59K -- | -5.59M -43.42% | 28.00K -95.03% | -45.54M -714.36% | 1.57M +5507.14% | 869.00K +101.91% | 0 -100.00% | -701.00K -- |
Net Interest Expense | 72.00K -- | -- -- | -- -- | -384.00K -633.33% | -- -- | -149.00K -- | -- -- | -338.00K +11.98% | -313.00K -110.07% | -603.00K -78.40% | -33.00K +89.46% | -301.00K +50.08% | -48.00K -45.45% | -316.00K -- |
Interest Expense | 72.00K -- | -- -- | -- -- | 83.00K +15.28% | -- -- | 44.00K -- | -- -- | 93.00K +12.05% | 60.00K +36.36% | 150.00K +61.29% | 134.00K +123.33% | 179.00K +19.33% | 35.00K -73.88% | 80.00K -- |
Interest Income | -- -- | -- -- | -- -- | 467.00K -- | -- -- | 193.00K -- | -- -- | 431.00K -7.71% | 373.00K +93.26% | 753.00K +74.71% | 167.00K -55.23% | 480.00K -36.25% | 83.00K -50.30% | 396.00K -- |
Pretax Income From Continuing Operations | -74.91M -- | -1.45K -- | -5.83K -- | -94.80M -26.55% | -355.96K -- | -3.42M -236301.38% | -651.61K -11080.61% | -240.81M -154.03% | -150.68M -4311.12% | -172.59M +28.33% | -35.21M +76.64% | -53.60M +68.94% | -12.54M +64.40% | -30.93M -- |
Income Tax Expense | -85.00K -- | -- -- | -- -- | 1.00K +101.18% | -- -- | 1.00K -- | -- -- | 1.00K -- | 10.00K +900.00% | 10.00K +900.00% | 0 -100.00% | 259.00K +2490.00% | 1.00K -- | 260.00K -- |
Current Income Tax | -263.00K -- | -- -- | -- -- | 1.00K +100.38% | -- -- | -- -- | -- -- | 1.00K -- | -- -- | 10.00K +900.00% | -- -- | 259.00K +2490.00% | -- -- | -- -- |
Deferred Income Tax | 178.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | -- -- |
Net Income | -74.82M -- | -1.45K -- | -5.83K -- | -94.80M -26.70% | -355.96K -- | -3.42M -236370.59% | -651.61K -11080.61% | -240.81M -154.03% | -150.69M -4310.13% | -172.60M +28.33% | -35.21M +76.64% | -53.86M +68.80% | -12.54M +64.39% | -31.19M -- |
Net Income Attributable to Owners of the Company | -74.82M -- | -1.45K -- | -5.83K -- | -94.80M -26.70% | -355.96K -- | -3.42M -236370.59% | -651.61K -11080.61% | -240.81M -154.03% | -150.69M -4310.13% | -172.60M +28.33% | -35.21M +76.64% | -53.86M +68.80% | -12.54M +64.39% | -31.19M -- |
Net Income Attributable to Common Stockholders | -74.82M -- | -1.45K -- | -5.83K -- | -94.80M -26.70% | -355.96K -- | -3.42M -236370.59% | -651.61K -11080.61% | -240.81M -154.03% | -150.69M -4310.13% | -172.60M +28.33% | -35.21M +76.64% | -53.86M +68.80% | -12.54M +64.39% | -31.19M -- |
Total Comprehensive Income | -74.82M -- | -- -- | -- -- | -94.80M -26.70% | -- -- | -3.42M -- | -- -- | -240.81M -154.03% | -150.69M -4310.13% | -172.60M +28.33% | -35.21M +76.64% | -53.86M +68.80% | -12.54M +64.39% | -31.19M -- |
Total Comprehensive Income Attributable to Owners of the Company | -74.82M -- | -- -- | -- -- | -94.80M -26.70% | -- -- | -3.42M -- | -- -- | -240.81M -154.03% | -150.69M -4310.13% | -172.60M +28.33% | -35.21M +76.64% | -53.86M +68.80% | -12.54M +64.39% | -31.19M -- |
Basic EPS | -0.21 -- | -- -- | -- -- | -3.37 -1504.76% | -0.03 -- | -0.12 -- | -0.05 -- | -844.95 -24972.70% | -2.55 -2025.00% | -231.99 +72.54% | -37.53 -1371.76% | -52.8 +77.24% | -11.37 +69.70% | -26.64 -- |
Basic EPS from Continuing Operations | -0.21 -- | -- -- | -- -- | -3.37 -1504.76% | -- -- | -0.12 -- | -- -- | -844.95 -24972.70% | -2.55 -2025.00% | -231.99 +72.54% | -37.53 -1371.76% | -52.8 +77.24% | -11.37 +69.70% | -26.64 -- |
Diluted EPS | -0.21 -- | -- -- | -- -- | -3.37 -1504.76% | -0.03 -- | -0.68 -- | -0.05 -- | -844.95 -24972.70% | -2.55 -275.00% | -231.99 +72.54% | -37.53 -1371.76% | -52.8 +77.24% | -11.37 +69.70% | -26.64 -- |
Diluted EPS from Continuing Operations | -0.21 -- | -- -- | -- -- | -3.37 -1504.76% | -- -- | -0.68 -- | -- -- | -844.95 -24972.70% | -2.55 -275.00% | -231.99 +72.54% | -37.53 -1371.76% | -52.8 +77.24% | -11.37 +69.70% | -26.64 -- |
You can ask Aime
What is the revenue and EPS growth rate for Apollomics year over year?What does Apollomics do and what are its main business segments?What were the key takeaways from Apollomics's earnings call?What is Apollomics's latest dividend and current dividend yield?Did Apollomics beat or miss consensus estimates last quarter?What factors drove the changes in Apollomics's revenue and profit?What is the market's earnings forecast for Apollomics next quarter?What is Apollomics's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
